Marketing-authorisation holder · United States

Rosemont

United States5 medicines1 country

5 medicines in 1 country, as authorisation holder.

Its medicines

Group structure

Part of

RosemontPharmaceutical group

Other companies in the group

Headquarters not stated1

Rosemont Pharmaceuticals Ltd

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

5 medicines

Medicine	Substance	Country	Status	Authorised
ATMEKSI750mg(5ml) \| 750mg/5ml · Suspension	Methocarbamol	United States	Marketed	2025
FIBRICOR105mg \| 35mg · Tablet	Fenofibric acid	United States	Not marketed	2009
NEXICLON XR0.17mg base \| 0.26mg base · Tablet, extended release	Clonidine	United States	Marketed	2009
QDOLO5mg/ml · Solution	Tramadol	United States	Not marketed	2020
VOSTALLY1mg/ml · Solution	Ramipril	United States	Not marketed	2025

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Marketing-authorisation holder · United States

Rosemont

United States5 medicines1 country

5 medicines in 1 country, as authorisation holder.

Its medicines

Group structure

Part of

RosemontPharmaceutical group

Other companies in the group

Headquarters not stated1

Rosemont Pharmaceuticals Ltd

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

5 medicines

Medicine	Substance	Country	Status	Authorised
ATMEKSI750mg(5ml) \| 750mg/5ml · Suspension	Methocarbamol	United States	Marketed	2025
FIBRICOR105mg \| 35mg · Tablet	Fenofibric acid	United States	Not marketed	2009
NEXICLON XR0.17mg base \| 0.26mg base · Tablet, extended release	Clonidine	United States	Marketed	2009
QDOLO5mg/ml · Solution	Tramadol	United States	Not marketed	2020
VOSTALLY1mg/ml · Solution	Ramipril	United States	Not marketed	2025

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	5	5	0	Companies All medicines

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

rosemont pharms

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Marketing-authorisation holder
Group: Rosemont
Headquarters: United States
Medicines: 5
Countries: 1
Roles: Authorisation holder

United States: more companies

Ranked by their number of medicines.

Show all